Submit Deal

Kendall Investor Relations

Summary

Kendall IR is an investor relations firm in Cambridge, MA providing senior-level strategic and operational IR services for the biotech industry.

Market Context

Deals Overview

Edit Data

Total Deals6

Valued Deals5

Total Value£ 1.82 B

Avg. Deal Size£ 364 M

06 Aug 2024|United States|Biotechnology

Target: SERES THERAPEUTICS (VOWST BUSINESS)

Bidder: NESTLE HEALTH SCIENCE

7 Service Providers

2 Bidder | 5 Vendor

8 Dealmakers

2 Bidder | 6 Vendor

£ 399 M

Value

26 Jan 2023|United States|Pharmaceuticals

Target: LONGEVITY BIOMEDICAL

Bidder: DENALI CAPITAL ACQUISITION CORP

7 Service Providers

4 Target | 3 Bidder

4 Dealmakers

3 Target | 1 Bidder

£ 191 M

Value

09 Jan 2023|United States|Biotechnology

Target: VOYAGER THERAPEUTICS

Bidder: NEUROCRINE BIOSCIENCES

3 Service Providers

2 Target | 1 Bidder

8 Dealmakers

4 Target | 4 Bidder

£ 144 M

Value

01 Sep 2022|United States|Biotechnology

Target: FORMA THERAPEUTICS

Bidder: NOVO NORDISK

9 Service Providers

6 Target | 3 Bidder

65 Dealmakers

46 Target | 19 Bidder

£ 944 M

Value

01 Aug 2022|Cayman Islands|Biotechnology

Target: STEALTH BIOTHERAPEUTICS

Bidder: MORNINGSIDE VENTURE CAPITAL

9 Service Providers

5 Target | 4 Bidder

8 Dealmakers

5 Target | 3 Bidder

n/a

Value

13 Apr 2021|United States|Biotechnology

Target: REPERTOIRE IMMUNE MEDICINES

Bidder: FLAGSHIP PIONEERING

8 Service Providers

3 Target | 5 Bidder

17 Dealmakers

3 Target | 14 Bidder

£ 137 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy